Polidocanol – A Versatile and Safe Agent?

Key words

thoracic surgery - coronary bypass surgery - cardiovascular surgery

References

• 1 Celik B, Aydin O, Cilingir A, Basoglu A. A comparison of the effectiveness of talc, polidocanol and ethanol as pleural sclerosing agents in rabbits.  Thorac Cardiovasc Surg. 2009;  57 (2) 102-106
• 2 Badon A. Sclerotherapy of hemorrhoids.  Phlebologie. 1980;  33 (4) 613-616
• 3 Paquet K J. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices – a prospective controlled randomized trial.  Endoscopy. 1982;  14 (1) 4-5
• 4 Saito N, Sasaki S, Sekido M, Furukawa H, William M, Yamamoto Y. Efficacy of polidocanol sclerotherapy for capillary malformation with masked venous malformation.  Dermatol Surg. 2009;  35 (1) 161-164
• 5 Rabago D, Best T M, Zgierska A, Zeisig E, Ryan M, Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet rich plasma.  Br J Sports Med. 2009;  21
• 6 Huber-Riffeser G. Allergic contact dermatitis to polidocanol (Thesit).  Contact Dermatitis. 1978;  4 (4) 245
• 7 Sylvoz N, Villier C, Blaise S, Seinturier C, Mallaret M. Polidocanol induced cardiotoxicity: a case report and review of the literature.  J Mal Vas. 2008;  33 (4–5) 234-238
• 8 Marrocco-Trischitta M M, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.  Dermatol Surg. 2002;  28 (2) 153-155